PIK3CD has been implicated in the progression of various solid tumors, including colorectal, breast, and hepatocellular carcinoma, with its role in tumor growth and treatment resistance offering avenues for therapeutic interventions [54]. The gene discussed is PIK3CD; the disease is neoplasm.